✦ LIBER ✦

Intraperitoneal High-Dose Cisplatin and Etoposide with Systemic Thiosulfate Protection in Second-Line Treatment of Advanced Ovarian Cancer

✍ Scribed by Henric Malmström; Svein Rasmussen; Ernst Simonsen

Book ID: 115615820
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 328 KB
Volume: 49
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1993.1101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal high-dose cisplatin and

Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer

✍ H. Malmstrom; S. Rasmussen; E. Simonsen 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Phase II study of intraperitoneal cispla

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer

✍ R.S. de Jong; P.H.B. Willemse; H. Boonstra; E.G.E. de Vries; W.T.A. van der Graa 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 634 KB

Efficacy and safety of high-dose cisplat

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

✍ Francesco Re; Silvia Bohm; Saro Oriana; Gian Battista Spatti; Franco Zunino 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 655 KB

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C

✍ Paul J. Hesketh; Sualp Tansan; Priscilla B. Caguioa; Ann Hesketh; Rita Blanchard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Intraperitoneal Cisplatin and Intravenou

Intraperitoneal Cisplatin and Intravenous Paclitaxel in the Treatment of Epithelial Ovarian Cancer Patients with a Positive Second Look

✍ S. Makhija; P. Sabbatini; C. Aghajanian; E. Venkatraman; D.R. Spriggs; R. Baraka 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Second-Line Treatment with Intravenous G

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB